New treatment option for Spinal Cord Injury
Official title Tele-Exercise to Promote Empowered Movement in Individuals With Spinal Cord Injury
ClinicalTrials.gov ID: NCT07022808
What this study is testing
- What it's testing
- To achieve our specific aims and hypotheses we will conduct a parallel group mixed methods randomized control trial comparing participation in the TEEMS program with exercise via asynchronous video library equivalent (control). The use of mixed methods will allow for the integration of quantitative findings with the qualitative, lived perspective of participants to provide a comprehensive analysis of the tele-exercise program outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- at least 12 months post SCI (motor spinal level C5 or below)
- between 18-75 years of age
- ability to elevate shoulders \>25% range
- use assistive technology for mobility
- not currently receiving structured rehabilitation (i.e. new episode of inpatient or outpatient rehabilitation services to treat a new or exacerbated...
You likely can't join if
- Known or suggestive cardiovascular, metabolic, and/or renal disease and/or presence of absolute or relative contraindications to exercise...
- self-report previous hospitalization within a month,
- self report active pressure injury
- self report recent osteoporotic fracture
- self-report uncorrectable vision loss,
- self-report preexisting neurological conditions other than SCI
See the full eligibility criteria
- at least 12 months post SCI (motor spinal level C5 or below)
- between 18-75 years of age
- ability to elevate shoulders \>25% range
- use assistive technology for mobility
- not currently receiving structured rehabilitation (i.e. new episode of inpatient or outpatient rehabilitation services to treat a new or exacerbated mobility issue. Individuals attending outpatient services for ongoing...
- screened and medically cleared (if appropriate) for participation using the American College of Sports Medicine (ACSM) Preparticipation Health Screening Tool. The ACSM Health Screen helps to determine if an individuals...
- internet access to attend synchronous exercise classes
- Known or suggestive cardiovascular, metabolic, and/or renal disease and/or presence of absolute or relative contraindications to exercise participation that is considered unsafe by their medical team
- self-report previous hospitalization within a month,
- self report active pressure injury
- self report recent osteoporotic fracture
- self-report uncorrectable vision loss,
- self-report preexisting neurological conditions other than SCI
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.